A series of studies led by a University at Buffalo psychologist involving a group of Rhesus monkeys and a bottlenose dolphin suggest that some animals have functional features of, or parallels to, human conscious metacognition.
The University at Buffalo's Center for Computational Research will be a major participant this week in Grid2003, one of the largest public displays of an international computational grid running numerous applications across dozens of sites involving thousands of processors.
The University at Buffalo has established the Center for Unified Biometrics and Sensors, a new, cross-disciplinary center that takes a unique approach to developing technologies in biometrics, the science of identifying individuals based on their physical, chemical or behavioral characteristics.
Physicians have treated chronic pain with antidepressants for many years, knowing that the medications -- particularly the drug with the scientific name amitriptyline -- helped many sufferers, but they didn't know how it worked as a pain reliever.
The University at Buffalo School of Management will offer a new MBA concentration in biotechnology management beginning in Fall 2004. The curriculum is designed to provide a strong foundation of business principles vital to building a successful career in the biotechnology field.
The harvesting of a Caribbean soft coral off the coast of the Bahamas for use in a popular beauty product is providing a University at Buffalo marine biologist with an extraordinary experimental opportunity to answer fundamental questions about the ability of corals to survive environmental challenges.
Researchers from the University at Buffalo have developed a virtual-reality driving simulator that may help car-accident survivors recover from post-traumatic stress disorder (PTSD) -- a prevalent, but commonly untreated, condition associated with serious car accidents.
Four University at Buffalo faculty members recently were honored by the State University of New York for significant accomplishments in their respective academic fields.
University at Buffalo researchers using the latest computer-assisted technologies of genetic analysis have shown for the first time how a widely used drug for treating multiple sclerosis -- interferon beta (IFN-beta-1a) -- can modulate the expression of particular genes in patients being treated for the disease.
In a classic example of scientific research that has successfully outgrown the university lab where it was born, a University at Buffalo professor's unique method for designing and synthesizing anti-cancer compounds, called protein kinase inhibitors, is being commercialized.